Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids

Abstract Background Homozygous or compound heterozygous pathogenic variants in the thromboxane A synthase 1 (TBXAS1) gene are associated with Ghosal hematodiaphyseal dysplasia (GHDD) which is characterized by defective hematopoiesis and increased bone density of long bones. Methods Patients 1 and 2...

Full description

Bibliographic Details
Main Authors: Sun Young Kim, Alexander Ing, Shunyou Gong, Kai Lee Yap, Rukhmi Bhat
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.1494
_version_ 1818457658970079232
author Sun Young Kim
Alexander Ing
Shunyou Gong
Kai Lee Yap
Rukhmi Bhat
author_facet Sun Young Kim
Alexander Ing
Shunyou Gong
Kai Lee Yap
Rukhmi Bhat
author_sort Sun Young Kim
collection DOAJ
description Abstract Background Homozygous or compound heterozygous pathogenic variants in the thromboxane A synthase 1 (TBXAS1) gene are associated with Ghosal hematodiaphyseal dysplasia (GHDD) which is characterized by defective hematopoiesis and increased bone density of long bones. Methods Patients 1 and 2 are identical twins, who presented with red blood cell transfusion‐dependent normocytic anemia and thrombocytopenia with bone marrow fibrosis and cortical bone thickening of long bones on plain radiograph. To clarify the etiology of their anemia and thrombocytopenia, whole blood was used for the DNA extraction and analyzed using next‐generation sequencing (NGS) on an in‐house bone marrow failure syndrome panel. Results The NGS results indicated that these two patients carried two heterozygous variants in TBXAS1, exon7, c.583_584del, p.Ala195Leufs*12, and exon12, c.1420G>T, p.Gly474Trp, which were inherited from their mother and father, respectively. Patients 1 and 2 have been on chronic oral steroids with normalization of hemoglobin and platelet count after steroid initiation. Patient 3 is their sister who has normal blood counts but also has the same variants in TBXAS1 as her brothers. Radiographs showed cortical bone thickening and she has not required any treatment or transfusion. Conclusion We report three Caucasian siblings from non‐consanguineous parents with novel compound heterozygous variants of TBXAS1 presenting with the phenotypes of GHDD. These three cases illustrate the variable clinical expressivity of the GHDD from two‐compound heterozygous pathogenic variants of TBXAS1.
first_indexed 2024-12-14T22:46:04Z
format Article
id doaj.art-89f557845c7242cf8e2032614a26feab
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-12-14T22:46:04Z
publishDate 2021-03-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-89f557845c7242cf8e2032614a26feab2022-12-21T22:44:51ZengWileyMolecular Genetics & Genomic Medicine2324-92692021-03-0193n/an/a10.1002/mgg3.1494Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroidsSun Young Kim0Alexander Ing1Shunyou Gong2Kai Lee Yap3Rukhmi Bhat4Department of Pediatrics Division of Hematology/Oncology/Stem Cell Transplant Ann and Robert H. Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of Medicine Chicago IL USADepartment of Pathology & Laboratory Medicine Ann and Robert H. Lurie Children’s Hospital of ChicagoNorthwestern University Feinberg School of Medicine Chicago IL USADepartment of Pathology & Laboratory Medicine Ann and Robert H. Lurie Children’s Hospital of ChicagoNorthwestern University Feinberg School of Medicine Chicago IL USADepartment of Pathology & Laboratory Medicine Ann and Robert H. Lurie Children’s Hospital of ChicagoNorthwestern University Feinberg School of Medicine Chicago IL USADepartment of Pediatrics Division of Hematology/Oncology/Stem Cell Transplant Ann and Robert H. Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of Medicine Chicago IL USAAbstract Background Homozygous or compound heterozygous pathogenic variants in the thromboxane A synthase 1 (TBXAS1) gene are associated with Ghosal hematodiaphyseal dysplasia (GHDD) which is characterized by defective hematopoiesis and increased bone density of long bones. Methods Patients 1 and 2 are identical twins, who presented with red blood cell transfusion‐dependent normocytic anemia and thrombocytopenia with bone marrow fibrosis and cortical bone thickening of long bones on plain radiograph. To clarify the etiology of their anemia and thrombocytopenia, whole blood was used for the DNA extraction and analyzed using next‐generation sequencing (NGS) on an in‐house bone marrow failure syndrome panel. Results The NGS results indicated that these two patients carried two heterozygous variants in TBXAS1, exon7, c.583_584del, p.Ala195Leufs*12, and exon12, c.1420G>T, p.Gly474Trp, which were inherited from their mother and father, respectively. Patients 1 and 2 have been on chronic oral steroids with normalization of hemoglobin and platelet count after steroid initiation. Patient 3 is their sister who has normal blood counts but also has the same variants in TBXAS1 as her brothers. Radiographs showed cortical bone thickening and she has not required any treatment or transfusion. Conclusion We report three Caucasian siblings from non‐consanguineous parents with novel compound heterozygous variants of TBXAS1 presenting with the phenotypes of GHDD. These three cases illustrate the variable clinical expressivity of the GHDD from two‐compound heterozygous pathogenic variants of TBXAS1.https://doi.org/10.1002/mgg3.1494anemiaGhosal hematodiaphyseal dysplasiaTBXAS1thromboxane synthase 1
spellingShingle Sun Young Kim
Alexander Ing
Shunyou Gong
Kai Lee Yap
Rukhmi Bhat
Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
Molecular Genetics & Genomic Medicine
anemia
Ghosal hematodiaphyseal dysplasia
TBXAS1
thromboxane synthase 1
title Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
title_full Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
title_fullStr Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
title_full_unstemmed Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
title_short Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
title_sort novel compound heterozygous variants of tbxas1 presenting with ghosal hematodiaphyseal dysplasia treated with steroids
topic anemia
Ghosal hematodiaphyseal dysplasia
TBXAS1
thromboxane synthase 1
url https://doi.org/10.1002/mgg3.1494
work_keys_str_mv AT sunyoungkim novelcompoundheterozygousvariantsoftbxas1presentingwithghosalhematodiaphysealdysplasiatreatedwithsteroids
AT alexandering novelcompoundheterozygousvariantsoftbxas1presentingwithghosalhematodiaphysealdysplasiatreatedwithsteroids
AT shunyougong novelcompoundheterozygousvariantsoftbxas1presentingwithghosalhematodiaphysealdysplasiatreatedwithsteroids
AT kaileeyap novelcompoundheterozygousvariantsoftbxas1presentingwithghosalhematodiaphysealdysplasiatreatedwithsteroids
AT rukhmibhat novelcompoundheterozygousvariantsoftbxas1presentingwithghosalhematodiaphysealdysplasiatreatedwithsteroids